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Abstract
Background: Plasmodium berghei ANKA infection in C57Bl/6 mice induces cerebral malaria (CM), which reproduces,
to a large extent, the pathological features of human CM. However, experimental CM incidence is variable (50-
100%) and the period of incidence may present a range as wide as 6-12 days post-infection. The poor
predictability of which and when infected mice will develop CM can make it difficult to determine the causal
relationship of early pathological changes and outcome. With the purpose of contributing to solving these
problems, algorithms for CM prediction were built.
Methods: Seventy-eight P. berghei-infected mice were daily evaluated using the primary SHIRPA protocol. Mice
were classified as CM+ or CM- according to development of neurological signs on days 6-12 post-infection.
Logistic regression was used to build predictive models for CM based on the results of SHIRPA tests and
parasitaemia.
Results: The overall CM incidence was 54% occurring on days 6-10. Some algorithms had a very good
performance in predicting CM, with the area under the receiver operator characteristic (auROC) curve ≥ 80% and
positive predictive values (PV+) ≥ 95, and correctly predicted time of death due to CM between 24 and 72 hours
before development of the neurological syndrome (auROC = 77-93%; PV+ = 100% using high cut off values).
Inclusion of parasitaemia data slightly improved algorithm performance.
Conclusion: These algorithms work with data from a simple, inexpensive, reproducible and fast protocol. Most
importantly, they can predict CM development very early, estimate time of death, and might be a valuable tool for
research using CM murine models.
Background
Cerebral malaria (CM) is one of the most important
complications of Plasmodium falciparum infection. It is
estimated that one in each four survivors may develop
prolonged neurological and cognitive deficits [1]. CM is
a multi-factorial disease with a poorly understood
pathophysiology, but a number of host, parasite and
epidemiological factors have been shown to play a role
or influence pathogenesis [2-9]. Although no
experimental model can fully reproduce all the aspects
of the human disease, the murine models of CM have
been instrumental in the study of CM
physiopathogenesis, the most widely used model being
the infection of different susceptible mouse strains by
Plasmodium berghei ANKA [10], which shares many
features with human CM [11]. Plasmodium berghei
ANKA-infected susceptible mice develop a lethal
neurological syndrome 6-12 days after infection with a
cumulative incidence of 50-100% [12-14].
A number of approaches have been used to
understand CM pathogenesis in the murine model,
including interventional approaches, such as the
blockage or addition of a given mediator [15],
comparisons between CM-susceptible and resistant
mouse strains [16,17] or between CM-inducing and
non-inducing parasite strains [18,19]. Most approaches
make it possible to demonstrate whether a factor is
needed or not for the pathogenic process, but the
precise role of each mediator and, mainly, a clear
definition of the sequence of events during the course of
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any medium, provided the original work is properly cited.the disease are difficult to determine. In particular, the
association of physiopathological changes occurring
early during infection with outcome, which is crucial for
the understanding of CM pathogenesis, is curtailed by a
number of factors related to the experimental model.
First, the incidence of CM is variable among
experiments, and can be as low as 50% [20]. Second,
CM incidence can be spread over several days, most
deaths occurring usually between days 6 and 9, but it
can happen as early as day 5 and as late as day 12 of
infection [12-14]. Therefore, the day of infection is
usually a poor indicator of disease stage and, unless
strict clinical assessment is performed, analyses based
on the time of infection may give origin to bias derived
from the different stages of the disease in different
animals. Third, neurological signs (ataxia, convulsions,
roll over, paralysis, coma) develop only few hours before
death. Moreover, different host-parasite factors such as
genetic background, age, inoculum size, course of
parasitaemia and clonal variations of the parasite also
interfere with the incidence of CM in mice [13,17,20].
These variations can, therefore, be a drawback for some
experimental designs, for instance, in sequential studies
aiming to identify early pathological changes related to
CM development since, without a tool for predicting the
outcome (development or not of the neurological
syndrome), it may be complicated to determine which
early changes are related to a given outcome. A way to
solve or minimize this problem is to use factors or tests
to build predictive models that can timely discriminate
susceptible P. berghei ANKA-infected mice that will
(CM+) or will not (CM-) develop CM.
It has been previously shown that a temperature below
30°C [21], the course of parasitaemia [22], and changes
in locomotor activity [23] and in the TCR-b repertoire
[ 1 0 ]a r ea s s o c i a t e dw i t hd e a t ho fP. berghei ANKA-
infected mice. Lackner and colleagues [24], using a well-
established protocol for behavioural evaluations in mice,
the SHIRPA protocol, showed that CM+ mice present
behavioural alterations strongly associated with a poor
outcome 36 h prior to death. However, the study does
not provide a tool for predicting CM development. The
aim of the present study was to develop algorithms
using logistic regression based on mouse behaviour data
obtained with the SHIRPA primary screen and the levels
of parasitaemia for early prediction of CM development
in C57Bl/6 mice infected with P. berghei ANKA.
Methods
Mice
A total of 78 six- to eight-week-old female C57Bl/6 mice
were obtained from CECAL/Fiocruz (Rio de Janeiro,
Brazil) and used in five separate experiments. All mice
were bred under specific pathogen-free (SPF) conditions
and housed in groups of five (maximum), in plastic
cages, with autoclaved food (Nuvital, Brazil) and filtered
and autoclaved water ad libitum. All experimental
protocols were reviewed and approved by the Fiocruz
Ethics Committee on Animal Use (license number L-
079/08).
Parasite and infection
Plasmodium berghei ANKA strain was stored in
Alsever’s solution in liquid nitrogen until use. A sample
was thawed and 100 μL were injected intraperitoneally
(i.p.) into a donor mouse of the same age as the
experimental group mice. Three days later, blood was
collected and 1 × 10
6 parasitized red blood cells (pRBC)
were inoculated i.p. into each animal of the
experimental group. Thin blood smears were daily made
with a blood drop collected from the tip of the tail,
stained according to the Panoptic method (Laborclin,
Brazil) and examined under a light microscope (BH2,
Olympus: Melville, New York, USA) with an oil
immersion lens (1,000× final magnification).
Parasitaemia levels were measured by counting the
percentage of pRBC in at least 2,000 RBC. Mice were
observed three times a day and CM diagnosis was made
based on presentation of neurological clinical signs
(ataxia, disorientation, paraplegia, roll-over and coma)
on days 5 - 12 post-infection.
Behavioural analyses
In order to provide a behavioural and functional profile
of mice every 24 hours, from day 4 to day 10 of
infection, SHIRPA primary screen was used as described
elsewhere [25]. This protocol is composed of 40
separate parameters that provide a wide range of
behavioural, neurological, and physiological measures.
Briefly, each mouse was put under a clear cylinder with
a diameter of 15 cm and 11 cm of height, which was
located on a steel grid of about 1-cm mesh size. For 5
min, its behaviour was observed, the amount of rearing,
grooming, and faecal pellets were counted and urination
was scored as present or not. Subsequently, the mouse
was transferred to a clear Perspex arena (55 × 33 cm)
for evaluating the transfer arousal and observation of
motor behaviour. Afterwards, a sequence of
manipulations using tail suspension was performed and
grip strength, body tone, and reflexes were recorded. To
complete the assessment, the animal was restrained in a
supine position to record autonomic behaviours prior to
measurement of the righting reflex. Throughout this
procedure, vocalization, urination, fear, irritability and
aggression were recorded. All behaviours were scored to
provide a quantitative assessment of each parameter as
proposed by Hatcher et al [26]. Startle response, body
length and temperature were not assessed. The values of
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positional passivity, wire manoeuvre, lacrimation,
salivation, provoked biting, righting reflex, negative
geotaxis, and fear were reversed to get a more
reasonable physiological behaviour; i.e., the best and
worst scores valued maximum and minimum points,
respectively [24]. A detailed description of the tests and
scoring system is provided as supplemental material
(See Additional file 1: SHIRPA Protocol - Primary
screen). A total score and scores measuring different
neurological functions - reflex and sensory function,
neuropsychiatric state, motor behaviour, autonomous
function, and muscle tone and strength - were
generated grouping individual scores obtained in each
evaluation, as previously described [24,26]. However,
different from Lackner et al [24], parameters were not
normalized to a percentage of their respective maximum
value before being summed up.
Statistical analyses
Results of parasitaemia levels were expressed as means
and standard errors of the mean (SEM). The initial
statistical analyses of the SHIRPA individual scores were
performed by nonparametric tests. Based on the scale of
the individual parameter, Fisher’se x a c tt e s t( ≤ 3
parameter values) or Wilcoxon rank-sum test (if > 3
parameter values) was used to compare CM+ and CM-
mice in the same day of infection. Wilcoxon matched-
pairs signed-ranks test was also used to evaluate the
equality of matched pairs of observations from CM- mice
on days 4 - 6 of infection. A p value of less than 0.05 was
considered to indicate statistical significance. Kaplan-
Meier curves were used to evaluate survival pattern of
mice.
Multiple logistic regression analyses were used to
identify which SHIRPA individual items were the most
important prognostic factors for the occurrence of CM.
In multiple logistic regressions, a forward stepwise
selection procedure was performed using a p-value of
0.3 for the association with CM as the criterion for
entering variables in the model. A backward stepwise
elimination procedure was then performed, with a p-
value of 0.05 as the criterion for remaining in the
model.
Predictive models based on a scoring system, with
points allocated to each prognostic factor, were created
from the final logistic regression model run in the test
sample for days 4-6 of infection. The scoring system for
each day was generated by dividing the value of the
regression coefficient of each variable by the smallest
coefficient and rounding the quotients to the closest
integer [27]. As an example, tail elevation on day 4 had
a regression coefficient of 1.115, which was then divided
by the coefficient of faecal pellets (b = 0.2136), resulting
in an approximate value of 5 (Item4 score, Figure 1a).
The final score was obtained through the sum of each
SHIRPA individual test score for those variables that
remained in the final model multiplied by the coefficient
generated. This approach resulted in the selection of
individual SHIRPA tests that, when grouped, provided
the best possible predictive power for CM development
when applied on day 4 (Item4), day 5 (Item5)o rd a y6
(Item6). For example, to obtain the final Item4 score for
a mouse that had the following parameters on day 4:
grooming in jar = 1; faecal pellets = 5; tail elevation = 3;
limb tone = 1; trunk curl = 1; visual placing = 3; grip
strength = 2; body tone = 1; pinna reflex = 1; corneal
reflex = 1; contact righting reflex = 1; and aggression =
0, we used the formula shown in Figure 1a, as follows:
Item4 score = 1 + 5 + (3 * 5) + (1 * (-4)) + (1 * (-10)) +
(3 * (-10)) + (2 * (-10)) + (1 * (-10)) + (1 * (-10)) + (1 *
(10)) + (1 * (-10)) + (0 * 10), which would lead to a
score of -63 points for a mouse presenting those
characteristics.
In the case-control study, cases were considered as
mice that died in a certain time following infection (e.g.,
day 6) and controls were those CM- mice at that time.
This selection procedure was repeated for each day of
infection in which CM+ mice died. Based on this
sampling scheme, separate data sets were built for
predicting death with CM 24, 48, 72 and 96 hours
before. For example, in the “24 h-data set”, the SHIRPA
individual scores and parasitaemia levels 24 hours
before death were recorded for cases and 24 h before
that selected day for controls. The same procedure was
used for the 48-, 72-, and 96-hour data sets. A new
variable indicating the day of infection was created and
w a sa l w a y sc o n s i d e r e di nt h emodels. Then, predictive
scores were built in a similar way than those generated
for each day of infection.
A cross-validation procedure was performed by
randomly deleting one observation at a time, then
predicting each removed individual from a model fit
from the remaining data. This procedure was repeated
many times and sensitivity and specificity of which were
calculated with predictions from the models. The data
that did not include the observations were used to fit
the model. Cross-validated goodness-of-fit tests were
also calculated [28]. The area under the receiver
operator characteristic (auROC) curve, sensitivity,
specificity, and predictive values were used to evaluate
models’ performances. Predictive scores built in the
case-control study were also evaluated in the original
data set using the same cross-validation method to test
models’ performances in practice. All statistical analyses
were performed using Stata 9.0.
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CM development
Inoculation of P. berghei ANKA to C57Bl/6 mice resulted
in a lethal infection with a 100%-cumulative mortality on
day 17. The cumulative incidence of CM was 54.3%,
occurring on days 6 to 10 (Figure 2a). Mice that showed
CM neurological signs (CM+ mice) died shortly thereafter,
usually within a few hours. The remaining mice not
affected by CM (CM- mice) died later on days 12-17 by
other malaria-related pathologies (hyperparasitaemia,
severe anemia) without showing any neurological sign.
Course of parasitaemia
Parasitaemia was first detected 2 days after inoculation
and grew rapidly for all infected mice up to day 4 of
infection. As we have previously shown for other strains
of mice [22], parasitaemia levels on subsequent days
were critical for the outcome in terms of CM
development. Indeed, parasitaemia levels in CM+ mice
were significantly higher as compared to CM- mice on
days 4 - 7 of infection (p < 0.05 in all time points,
Figure 2b). Mice showing CM signs on days 9 - 10 had
a different course of parasitaemia resembling CM-
animals, being considered as “Late CM+” (Figure 2b).
Figure 1 Scores designed for prediction of CM using logistic regression. Item and Item+P scores were designed for prediction of CM using
a stepwise multiple logistic regression analysis to identify the most important prognostic factors of SHIRPA individual scores for the occurrence
of CM. Itemx and Item+Px scores are based on the day of infection and made to select animals that will develop CM. Item
y and Item+P
y scores
were made to predict if mice will develop CM after 24, 48 or 72 hours. RIJ = Rearing in Jar; GIJ = Grooming in Jar; U = Urination; FP = Faecal
Pellets; BP = Body Position; SA = Spontaneous Activity; RRa = Respiration Rate; T = Tremor; TA = Transfer arousal; LA = Locomotor Activity; RIA =
Rearing in Arena; PC = Palpebral Closure; Pi = Piloerection; G = Gait; PE = Pelvic Elevation; TE = Tail Elevation; TEs = Touch Escape; PP =
Positional Passivity; TC = Trunk Curl; LG = Limb Grasping; VP = Visual Placing; GS = Grip Strength; BT = Body Tone; PR = Pinna Reflex; CR =
Corneal Reflex; TP = Toe Pinch; WM = Wire Manoeuvre; SC = Skin colour; HR = Heart Rate; LT = Limb Tone; AT = Abdominal Tone; L =
Lacrimation; S = Salivation; PB = Provoked Biting; RR = Righting Reflex; CRR = Contact Righting Reflex; NG = Negative Geotaxis; F = Fear; I =
Irritability; A = Aggression; V = Vocalization.
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whether parasitaemia levels on days 2-9 of infection
predict the risk of CM development. Parasitaemia level
of each mouse on days 4-7 was associated with the risk
of CM development. Results from these logistic
regression models on days 4-6 are shown in Table 1.
On day 7, p-value was 0.015 and the odds ratio (OR)
value was 1.068 (95% CI = 1.013-1.126). Parasitaemia
level on other days was not associated with the risk of
CM (p > 0.05).
One example of the associative strength is the OR
value for parasitaemia level observed on day 5 (OR =
1.080), indicating that an increase in the parasitaemia
level by one unit raised the odds of CM development by
8% (Table 1). As CM+ mice started to show
neurological signs and died on day 6, these data show
that parasitaemia levels might be used to predict CM
development at least 48 hours previous to death.
Figure 2 Survival curve (A) and course of parasitaemia (B) of mice infected with Plasmodium berghei ANKA.C 5 7 B l / 6a n i m a l sw e r e
infected with 1 × 10
6 Plasmodium berghei ANKA-parasitized red blood cells. CM+ = mice that developed cerebral malaria on days 6 - 8 after
infection; CM- = mice that did not develop cerebral malaria; Late CM+ = mice that developed cerebral malaria on days 9 and 10 after infection.
Results are expressed as means in (A) and means ± SEM in (B).
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To evaluate whether parameters from the SHIRPA
primary screen were associated with CM development on
days 4-6 of infection, individual scores obtained in each
evaluation from CM+ mice were compared with those
obtained from CM- mice on the same day (See Additional
file 2: Supplementary Table). Total and functional
category scores between CM+ and CM- mice were also
compared. On day 4, none of the individual tests were
significantly associated with CM development (p > 0.05
for all tests) and concordantly total and functional scores
were also not associated (p > 0.05 for all scores). On day 5,
nine tests were associated with CM (p < 0.05 for rearing in
jar, locomotor activity, rearing in arena, touch escape, limb
grasping, wire manoeuvre, lacrimation, righting reflex and
vocalization). The majority of these tests measure motor
behaviour (locomotor activity, limb grasping, and wire
manoeuvre) and neuropsychiatric state (touch escape and
vocalization), explaining the association found among
these functional scores and CM (p < 0.001 and p = 0.027
respectively) on day 5. On day 6, twenty five tests were
significantly associated with CM development (p < 0.05
for rearing in jar, grooming in jar, body position, tremor,
transfer arousal, locomotor activity, rearing in arena,
palpebral closure, gait, pelvic elevation, tail elevation,
touch escape, trunk curl, limb grasping, body tone, pinna
reflex, toe pinch, wire manoeuvre, skin colour, limb tone,
provoked biting, righting reflex, contact righting reflex,
negative geotaxis and vocalization). Again the majority of
tests significantly associated with CM measure motor
behaviour (10 tests), but all functional scores included
tests significantly associated with CM on day 6 (reflex and
sensory function - 3 tests; neuropsychiatric state - 3 tests;
autonomous function - 2 tests; muscle tone and strength -
2 tests). On day 6, only the autonomous function score
was not associated with CM (p > 0.05). Two tests carried
out on day 5 (rearing in jar and rearing in arena) and four
tests on day 6 (rearing in jar, grooming in jar, rearing in
arena and contact righting reflex) were significantly
associated with CM in spite of not being considered for
the building of functional category and total scores by
Hatcher et al [26].
All comparisons were made considering CM+ and
CM- mice on the same day of infection because CM-
mice performance in 11 tests significantly changed
during the course of infection (faecal pellets, p = 0.025;
visual placing, p = 0.046; grip strength, p = 0.015;
corneal reflex, p = 0.025; toe pinch, p = 0.003; wire
manoeuvre, p = 0.026; righting reflex, p = 0.026; rearing
in jar, p = 0.017; urination, p = 0.045; spontaneous
activity, p = 0.047; piloerection, p = 0.025).
Results from logistic regression models used to assess
whether total and functional category scores on days 4-6
of infection predict the risk of CM development are
shown in Table 1. Total, motor behaviour and
neuropsychiatric state scores of each mouse on days 5 -
6 were associated with the risk of CM development
showing that these scores can be used to predict CM
development at least 24 hours previous to death. Reflex
and sensory function and muscle tone and strength
scores were also associated with CM, but only later on
(day 6) (Table 1).
Building and testing the predictive performance of scores
Since individual SHIRPA tests were not individually
associated with CM development on day 4 of infection,
different tests were combined in order to acquire
predictive power. In addition, functional category scores
indicate whether certain brain areas or functions are
compromised in CM+ mice during the course of
infection and are conceived to physiopathological
purposes rather than to prediction. This could explain
why these scores did not have a good predictive power
when obtained on day 4 of infection. Therefore, new
scores for days 4 - 6 were built assigning weights to
each functional category score or making different
combinations of specific SHIRPA tests (Itemx scores,
Figure 1) aiming at improving early prediction of CM.
As parasitaemia levels showed to be an early but not
very powerful predictor of CM, we also built scores
Table 1 Association between parasitaemia level, total and functional category scores and the risk of CM development.
Score Day 4 Day 5 Day 6
OR p-value 95% CI OR p-value 95% CI OR p-value 95% CI
Parasitaemia 1.250 *0.048 1.002-1.560 1.080 *0.010 1.018-1.145 1.093 *0.001 1.039-1.151
Total 1.042 0.371 0.952-1.141 0.910 *0.003 0.855-0.969 0.907 * < 0.001 0.858-0.958
Reflex 0.978 0.941 0.548-1.746 0.928 0.682 0.650-1.325 0.491 * < 0.001 0.330-0.730
Neuro 0.981 0.923 0.669-1.438 0.719 *0.031 0.532-0.970 0.644 *0.001 0.495-0.839
Motor 1.000 0.998 0.892-1.122 0.833 *0.001 0.749-0.926 0.829 * < 0.001 0.747-0.920
Auto 1.186 0.299 0.859-1.638 0.932 0.393 0.793-1.095 0.883 0.185 0.735-1.061
Muscle 0.352 0.114 0.096-1.287 0.764 0.429 0.393-1.488 0.304 *0.001 0.148-0.621
Association between parasitaemia level, total and functional category scores based on the first screen of SHIRPA protocol on days 4-6 of infection and the risk of
CM development in C57Bl/6 mice infected with P. berghei ANKA. OR = Odds Ratio; 95% CI = 95% Confidence Interval for odds ratio. *Denotes statistical
significance in this table.
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scores (Item+Px scores, Figure 1). Generated scores with
the highest performance for each day are shown in
Figures 1a, b, c, d, e and 1f.
As hypothesized, auROC curves increased when
different weights were given to each functional score
(from 38% to 66% on day 4, 72% to 78% on day 5 and
85% to 91% on day 6). auROC curves increased when
parasitaemia levels were considered in the model on day
4 and 5 (from 66% to 73% on day 4 and from 78% to
82% on day 5), but this phenomenon did not happen on
day 6. When only the most predictive tests for each day
together with parasitaemia levels were considered,
auROC curves increased even more (auROC curves =
80%, 96% and 95% on days 4 - 6, respectively). As
expected, auROC curves increased with the proximity of
the neurological syndrome manifestation, being more
powerful on days 5 and 6 post-infection (72 - 96% and
85 - 95%, respectively) than on day 4 (38 - 80%).
Although generated scores were generally more sensitive
than specific, a relatively high prevalence of CM in the
experiments may explain why it was observed positive
predictive values (PV+) higher than negative predictive
values (PV-) for most analysed scores. High PV+ values
(≥ 92%) obtained for Item+Px scores on days 4-6
indicate that it is possible to early select mice with a
high probability of developing CM.
Case-control study
Although it is possible to early select CM+ mice using
the Item+Px scores generated as described above, this
kind of approach does not allow knowing on which day
post-infection mice will develop CM. Susceptible mice
can develop CM between day 6 and day 10, a long
period of at least 120 hours, showing that CM+ mice
selected by the generated scores are in different
pathophysiological states. This can be a problem
because some factors necessary or involved in CM
pathogenesis could be present only in the middle or late
in the course of infection, not being identified when the
entire CM+ selected population was analysed. A way to
solve this problem is to build scores to predict on which
day mice will develop CM. To accomplish this, a case-
control study controlled by the day of inoculation was
designed using the same experiments performed for
construction of the previous scores.
Scores were generated to predict whether a mouse
would develop CM in 24, 48, 72 or 96 hours later.
Again scores were generated assigning different
weights to each functional category score or making
different combinations of specific SHIRPA tests (Item
y
scores) together or not with parasitaemia (Item+P
y
scores). All generated scores for a 24 h-prediction
showed an excellent performance (auROC ≥ 84%) with
the Item+P
24 s c o r es h o w i n gt h eb e s tr e s u l t( auROC =
95%). Scores built for a 48 h-prediction had a good
performance (auROC between 78 - 94%) and the Item
+P
48 score had an equivalent performance when
compared to the Item+P
24 score (auROC = 94%). Only
Item+P
72 score had a good performance for a 72 h-
prediction (auROC = 85%), the remaining scores having
o n l yaf a i rp r e d i c t i v ep o w e r( auROC between 65 - 77%).
All predictive scores for 96 h had a poor performance
(auROC ≤ 72%). Again, auROC curves, sensitivity, and
specificity increased with the proximity of the
manifestation of the neurological signs, being more
powerful within 24 hours of death. In general,
specificity was greater than sensitivity for the
Table 2 Best predictive performance of different logistic regression models.
Score Day auROC S E PV+ PV- Acur. n Cut off Score Value
Item+P4 4 79 68 89 95 47 73 38 80 -57
Item5 5 92 64 100 100 64 78 59 95 -5
Item+P5 5 96 81 100 100 77 88 59 75 -46
Item6 6 94 76 100 100 73 86 57 90 -37
Item+P6 6 95 77 100 100 73 86 57 90 -1244
Item
24 5 77 25 100 100 95 95 61 40 -11
Item+P
24 5 85 25 100 100 95 95 61 55 -37
Item
48 6 91 14 100 100 89 89 56 85 250
Item+P
48 6 93 14 100 100 89 89 56 80 123
Item
72 4 82 46 100 100 77 80 37 65 -16
Item+P
72 4 82 61 100 100 82 86 37 65 -83
Best predictive performance of different logistic regression models for correctly select mice that will develop CM in C57Bl/6 animals infected with P. berghei
ANKA. Values are expressed in percents (%). auROC = area under the receiver operator characteristic; Se = sensitivity; Sp = specificity; PV+ = positive predictive
value; PV- = negative predictive value; n = total of mice analysed; Cut-off = estimated probability of developing CM above which the score is considered positive;
Score Value = score value corresponding to the respective cut off and above which a mouse can be considered positive in the score. Itemx = Item scores
designed for prediction of CM using the most important prognostic factors of SHIRPA individual scores on days 5 - 6 of infection; Item+Px = Item scores
associated with parasitaemia on days 4 - 6; Item
y = Item scores for 24, 48, 72 or 96 hours prediction designed using the most important prognostic factors of
SHIRPA individual scores; Item+P
y = Item scores associated with the levels of parasitaemia in the corresponding time.
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explained by the low prevalence of CM generated by
the case-control study design. The high specificity (≥
90%) of Item+P
24 and Item+P
48 scores indicates that
they will possibly have higher PV+ when applied in
practice and that they can be used to correctly classify
CM+ mice according to the day of CM development.
Generated scores with the highest performance are
s h o w ni nF i g u r e s1 g ,h ,i ,j ,ka n d1 l .
Algorithms to predict CM development
Whether Item+Px s c o r e sw o u l db eu s e di ns i t u a t i o n s
where a minimum error of 10% is acceptable, any of
them could be chosen to correctly identify CM+ mice.
However, for research purposes, an error of 10% is not
acceptable in many situations. It is possible to solve this
problem using a cut-off that improves specificity and PV
+ values. These analyses are shown in Table 2. As
hypothesized, increases in the cut-off values also
increases specificity and PV+ until values ≥ 95% for all
Itemx and Item+Px scores.
To verify Item
y and Item+P
y scores performance in
practice and determine cut-offs that improve their
specificities and PV+ values, these scores were cross-
v a l i d a t e di nt h eo r i g i n a ld a t as e tu s e df o rt h e
development of Itemx and Item+Px scores. The
performance of the best predictive scores on the best
days is also shown in Table 2. In general auROC curves
w e r e5-2 0 %w o r s eo nd a y s4-6t h a nw h e no b t a i n e d
in the case-control study. However, auROC curves
remained above 79% for Item+P
y and above 77% for
Item
y scores on some specific days (Table 2). It was also
Figure 3 A step by step protocol applied on day 4 post infection for predicting CM.I t e m + P 4 s c o r es h o u l db eu s e dt oe s t i m a t et h e
probability of CM development on any time between days 5 - 10 post infection. Item
72 and Item+P
72 should be used to estimate the
probability of CM development on day 7 post infection (72 hours after day 4 post infection). SHIRPA tests and its respective weights
compounding each score are shown in the third line. Values obtained for each SHIRPA test should be multiplied by its respective weight and
summed up to get a final score. A decision rule based on a specific final value for each score is shown. A final score above or equal (≥) this
value is considered positive and is associated with a high probability of cerebral malaria (CM) development. On the other hand, a final score
below this value (<) is considered negative and is associated with a low probability of CM. RIJ = Rearing in Jar; GIJ = Grooming in Jar; FP =
Faecal Pellets; SA = Spontaneous Activity; RRa = Respiration Rate; TE = Tail Elevation; TC = Trunk Curl; LG = Limb Grasping; VP = Visual Placing;
GS = Grip Strength; BT = Body Tone; PR = Pinna Reflex; CR = Corneal Reflex; LT = Limb Tone; RR = Righting Reflex; CRR = Contact Righting
Reflex; A = Aggression; P = Parasitemia.
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and PV+ values for these scores on specific days (Table
2). These data show that at any time between days 4
and 6 it is possible to predict with high level of
confidence which mice will develop CM (Figures 3, 4
and 5). Figures 3, 4 and 5 indeed provide researchers
with a simple, fast and powerful screening/prediction
tool that may prove useful in a wide range of
applications. Furthermore, in some specific situations it
is also possible to predict not only if but also when CM
will occur: i)o nd a y4i ti sp o s s i b l et od e f i n ew h i c h
mice will develop CM on day 7 using Item
72 and Item
+P
72; ii) on day 5 it is possible to define which mice will
develop CM on day 6 using Item
24 and Item+P
24; iii)o n
day 6 it is possible to define which mice will develop
CM on day 8 using Item
48 and Item+P
48 (Figures 3, 4
and 5). The cross-validation process revealed that
combinations other than these do not provide high
predictive powers.
Table 2 also show the score value that corresponds to
the respective cut-off. This value represents the
minimum value that a mouse must get in the respective
score to be considered as a CM+ mouse. For example, a
mouse with an Item+P4 score greater than -57 (-56,
-55...) on day 4 will be considered as positive. For this
cut-off point, the probability of CM development among
those considered positive is 95% (Figure 3).
Discussion
Previous studies showed that parameters as temperature
and parasitaemia levels are associated with CM
development and death in P. berghei ANKA-infected
mice [21-24], but only one study from our group [22]
measured the degree of this association (using hazard
ratio) and none of them showed estimates of sensitivity
and specificity for CM development. Collete et al [10]
showed that it is possible to discriminate CM+ from
CM- B10.D2 mice infected with P. berghei ANKA by
analysing the TCRb repertoire using a throughput
CDR3 spectratyping method. However, for being
sophisticated, expensive, and time-consuming, the use of
Figure 4 A step by step protocol applied on day 5 post infection for predicting CM.I t e m 5 and Item+P5 scores should be used estimate
the probability of CM development on any time between days 6 - 10 post infection. Item
24 and Item+P
24 should be used to estimate the
probability of CM development on day 6 post infection (24 hours after day 5 post infection). SHIRPA tests and its respective weights
compounding each score are shown in the third line. Values obtained for each SHIRPA test should be multiplied by its respective weight and
summed up to get a final score. A final score above or equal (≥) this value is considered positive and is associated with a high probability of
cerebral malaria (CM) development. On the other hand, a final score under this value (<) is considered negative and is associated with a low
probability of CM. RIJ = Rearing in Jar; U = Urination; BP = Body Position; RRa = Respiration Rate; T = Tremor; RIA = Rearing in Arena; G = Gait;
PP = Positional Passivity; TC = Trunk Curl; LG = Limb Grasping; GS = Grip Strength; TP = Toe Pinch; WM = Wire Manoeuvre; SC = Skin colour; AT
= Abdominal Tone; RR = Righting Reflex; NG = Negative Geotaxis; P = Parasitemia.
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Page 9 of 13Figure 5 A step by step protocol applied on day 6 post infection for predicting CM.I t e m 6 and Item+P6 scores should be used estimate
the probability of CM development on any time between days 7 - 10 post infection. Item
48 and Item+P
48 should be used to estimate the
probability of CM development on day 8 post infection (48 hours after day 6 post infection). SHIRPA tests and its respective weights
compounding each score are shown in the third line. Values obtained for each SHIRPA test should be multiplied by its respective weight and
summed up to get a final score. A final score above or equal (≥) this value is considered positive and is associated with a high probability of
cerebral malaria (CM) development. On the other hand, a final score under this value (<) is considered negative and is associated with a low
probability of CM. U = Urination; RRa = Respiration Rate; TA = Transfer arousal; LA = Locomotor Activity; RIA = Rearing in Arena; PC = Palpebral
Closure; Pi = Piloerection; PE = Pelvic Elevation; TE = Tail Elevation; PP = Positional Passivity; TC = Trunk Curl; LG = Limb Grasping; GS = Grip
Strength; BT = Body Tone; CR = Corneal Reflex; TP = Toe Pinch; WM = Wire Manoeuvre; SC = Skin colour; HR = Heart Rate; LT = Limb Tone; AT
= Abdominal Tone; PB = Provoked Biting; RR = Righting Reflex; CRR = Contact Righting Reflex; NG = Negative Geotaxis; F = Fear; A =
Aggression; V = Vocalization; Cons = constant; P = Parasitemia.
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Page 10 of 13this method for purposes of predicting CM does not
seem promising.
The SHIRPA protocol is reproducible across time and
laboratories [29,30] and it is a reliable tool for the
evaluation of the neurological function in murine models
of human disease [26,31-36]. Lackner et al [24] showed
that many scores obtained from the SHIRPA primary
screen are associated with CM development. However, the
purpose of the study was to provide researchers with a
tool for improved performance of clinical assessment of
CM mice, not as a tool for predicting CM development.
Our analyses confirm their data that motor behaviour and
neuropsychiatric state functions are early compromised in
the course of infection (day 5) and that scores measuring
muscle tone and strength, reflex and sensory function are
only compromised late in CM+ mice. On the other hand,
the performance of CM- mice also varied in the course of
infection at least in eleven tests on days 4-6, showing that
these mice have some degree of neurological impairment
during P. berghei ANKA infection. These data agree with
findings from Carvalho et al [37] showing that, although
CM incidence was 70% overall in their series, 100% of P.
berghei ANKA-infected CBA mice analysed presented
some degree of histological alteration in the brain on days
6-8 after infection; CM- mice had microhaemorrhages,
although in a much lower frequency than CM+ animals.
Animal models are important in guiding the discovery of
mechanisms of disease and potential targets for
prophylactic or therapeutic interventions, and they are as
well a critical step in testing new developed curative or
preventive interventions [38]. This is not different for CM
[15]. As predictive scores that correctly select CM+ mice
allow the study of these animals before the development
of CM, they have multiple applications in CM studies.
A major application for a predictive score for CM
murine models is on studies of pathophysiology. A sine
qua non condition to attribute causality is that the
factor must precede the outcome it is assumed to affect,
however temporal direction might be difficult to
establish if initial forms of disease, as happen in CM,
were difficult to observe [39]. As Itemx and Item+Px
scores can be used to correctly select CM+ mice before
the development of CM on days 4 - 6, pathologic
factors present in these mice that are not present in
CM- mice have a high probability to be part of the
causative mechanism of CM and not a consequence of
it. Furthermore, Item
y and Item+P
y scores can also help
to determine whether a given mediator is present 24, 48
or 72 hours before death in CM+ mice and whether the
blockage or addition of this mediator at the
corresponding time interfere with the outcome of the
disease. This approach is useful to analyse the temporal
sequence of appearance and time of exposition needed
so that different factors can cause CM in this model.
These predictive scores can also be a suitable tool for
preventive therapy and treatment studies allowing the
determination of how much time before death a drug or
intervention can change the outcome of the disease.
To be applied in practice, a score should be obtained
from a simple and fast process. Employing proposed
scores in practice is simple and direct using the scores
values showed in Table 2 and Figures 3, 4 and 5. In
addition, it is possible to calculate it very fast using a
computer algorithm. Per mouse, it takes up to 30
minutes to carry out the entire SHIRPA protocol and to
calculate parasitaemia levels by microscopy. This time
m a yb et o ol o n gf o rm a n ye x p e r i m e n t a la p p r o a c h e s ,
making Pond and Pond+P scores not suitable for
practical use. However Item scores are composed of 8
to 21 tests, taking between 6-11 minutes per mouse to
be applied. Unfortunately, parasitaemia levels alone had
a poor performance in predicting CM (auROC < 72%).
However, if we add this index to Item scores, time of
testing increases but remains reasonable, and can still be
shortened if other methods to estimate it, such as flow
cytometry, are used [40,41]. In addition, the
performance of Item scores was very good and similar
to that of Item+P scores to select CM+ mice (Table 2),
making Item scores applicable in practice.
Conclusion
The present study provides consistent data supporting
the idea that scores based on both the primary SHIRPA
and from measuring parasitaemia levels are associated
with and, then, can be used to predict the development
of CM induced by a P. berghei ANKA infection in
C57Bl/6 mice. The present study is the first to apply a
commonly accepted behavioural protocol to build
predictive scores of outcome in a well-established model
of cerebral infectious disease.
As “Item” and “Item+P” scores are derived from a
simple, highly reproducible, fast and cheap protocol, and
since our results showed that they can reliably identify
(or predict) CM+ mice and their time of death, we
think that these scores might be a valuable tool to
delineate the mechanisms underlying CM and for
research with CM murine models. Neurophysiological,
neuroanatomical, neurochemical and
neuropharmacological research with CM murine models
are some areas in which these scores can be applied.
Additional file 1: A protocol showing how the primary screen of
SHIRPA tests were performed and scored.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-2875-9-85-
S1.PDF]
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Page 11 of 13Additional file 2: Values of individual SHIRPA tests and functional
category scores of infected non-CM (CM-) mice on days 4 - 6 post-
infection were compared with cerebral malaria (CM+) mice in this Table.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-2875-9-85-
S2.DOC]
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